These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10757596)

  • 1. Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan.
    Waterman FM; Dicker AP
    Med Phys; 2000 Mar; 27(3):448-51. PubMed ID: 10757596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of postimplant edema on the urethral dose in prostate brachytherapy.
    Waterman FM; Dicker AP
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):661-4. PubMed ID: 10837949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer.
    Lee HK; D'Souza WD; Yamal JM; Pollack A; Lee AK; Palmer MB; Kuban DA
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):355-61. PubMed ID: 12957245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple technique for determining accurate urethral dosimetry after seed brachytherapy for prostate cancer.
    Millar JL; Longano AZ; Imbert SJ; Stokes D
    Brachytherapy; 2006; 5(1):27-31. PubMed ID: 16563994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
    Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the use of a surrogate urethra an option in prostate high-dose-rate brachytherapy?
    Nilsson J; Kälkner KM; Berg L; Levitt S; Holmberg C; Nilsson S; Lundell M
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):36-40. PubMed ID: 17980507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
    Yue N; Dicker AP; Corn BW; Nath R; Waterman FM
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):447-54. PubMed ID: 10030274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urethral and periurethral dosimetry in prostate brachytherapy: is there a convenient surrogate?
    Bucci J; Spadinger I; Hilts M; Sidhu S; Smith C; Keyes M; Morris WJ
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1235-42. PubMed ID: 12419453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of edema on urethral dose following palladium-103 prostate brachytherapy.
    Gejerman G; Mullokandov E; Saini AJ; Lanteri V; Scheuch J; Vitenson J; Rosen J; Garden R; Sawczuk I
    Med Dosim; 2002; 27(3):221-5. PubMed ID: 12374379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy.
    Butler WM; Merrick GS; Dorsey AT; Hagedorn BM
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1575-82. PubMed ID: 11121664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the feasibility of using transrectal ultrasound for postimplant dosimetry in low-dose-rate prostate brachytherapy.
    Davies RS; Perrett T; Powell J; Barber J; Tanguay J; Button M; Cochlin D; Smith C; Lester JF
    Med Dosim; 2016 Winter; 41(4):290-295. PubMed ID: 27623391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level.
    Pinkawa M; Gagel B; Asadpour B; Piroth MD; Klotz J; Borchers H; Jakse G; Eble MJ
    Strahlenther Onkol; 2008 Oct; 184(10):520-5. PubMed ID: 19016041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
    Stone NN; Hong S; Lo YC; Howard V; Stock RG
    Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of urethra visualization for preplanned permanent prostate implants.
    Sloboda RS; Pedersen JE
    Brachytherapy; 2005; 4(3):195-201. PubMed ID: 16182219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A surrogate urethra for real-time planning of high-dose-rate prostate brachytherapy.
    Halperin H; Hilts M; Crook J; Batchelar D; Tisseverasinghe S; Tetreault-LaFlamme A; Bachand F
    Brachytherapy; 2019; 18(5):675-682. PubMed ID: 31248822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmental urethral dosimetry and urinary toxicity in patients with no urinary symptoms before permanent prostate brachytherapy.
    Thomas C; Keyes M; Liu M; Moravan V
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):447-55. PubMed ID: 18395357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary morbidity after permanent prostate brachytherapy - impact of dose to the urethra vs. sources placed in close vicinity to the urethra.
    Pinkawa M; Holy R; Piroth MD; Klotz J; Pfister D; Heidenreich A; Eble MJ
    Radiother Oncol; 2012 May; 103(2):247-51. PubMed ID: 22300607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
    Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.